Investment ThemesDetailed Quotes
Cannabis & Hemp
Watchlist
The Cannabis concept includes major US-listed cannabis producers.
- 114.705
- -2.763-2.35%
Close Feb 14 16:00 ET
116.855High114.358Low
116.855Open117.468Pre Close60.10MVolume5RiseLossP/E (Static)322.90MTurnover2Flatline1.46%Turnover Ratio37.46BMarket Cap13Fall35.22BFloat Cap
Constituent Stocks: 20Top Rising: CPIX+10.99%
Sign in to post a comment
$Aurora Cannabis (ACB.US)$
Major Medical Cannabis Breakthrough: Aurora Unlocks Australia-Wide Patient Access to Top-Ranked Products
Major Medical Cannabis Breakthrough: Aurora Unlocks Australia-Wide Patient Access to Top-Ranked Products
1
1
$Veru Inc (VERU.US)$ Why's this tanking?
$Tilray Brands (TLRY.US)$ fuck this stock. CEOtake high salry without working... voted for him to resign
2
$Veru Inc (VERU.US)$ why didnt rise~
$Tilray Brands (TLRY.US)$ fucking piece of shitt mother fuckers ...I'll be getting my money bck Evan if have too take out you're ass
1
1
$Canopy Growth (CGC.US)$
Double Dose: Canopy Growth's New Cannabis Beverages Pack Root Beer and Cream Soda with Enhanced THC+CBG
Double Dose: Canopy Growth's New Cannabis Beverages Pack Root Beer and Cream Soda with Enhanced THC+CBG
1
$Veru Inc (VERU.US)$
taking a position here earning this morning
taking a position here earning this morning
1
1
when america wakes up
$Veru Inc (VERU.US)$ Veru (NASDAQ:VERU) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 25 percent increase over losses of $(0.08) per share from the same period last year.
1
4
$Veru Inc (VERU.US)$
The Phase 2b QUALITY study results represent a significant breakthrough in addressing a critical limitation of GLP-1 receptor agonists like Wegovy. The 71% reduction in lean mass loss and particularly the 99% preservation with the 3mg dose could position enobosarm as an essential companion therapy to GLP-1 drugs, especially for older adults where muscle preservation is crucial.
The body composition data is particularly compelling - while placebo + s...
The Phase 2b QUALITY study results represent a significant breakthrough in addressing a critical limitation of GLP-1 receptor agonists like Wegovy. The 71% reduction in lean mass loss and particularly the 99% preservation with the 3mg dose could position enobosarm as an essential companion therapy to GLP-1 drugs, especially for older adults where muscle preservation is crucial.
The body composition data is particularly compelling - while placebo + s...
3
$Veru Inc (VERU.US)$
Game-Changing Clinical Results: Veru's Drug Outperforms Weight Loss Giant Wegovy in Muscle Protection
Game-Changing Clinical Results: Veru's Drug Outperforms Weight Loss Giant Wegovy in Muscle Protection
No comment yet
Wolf Zone : this means down down down